Miriam C. Poirier
CDI Section
LCBG, CCR, National Cancer Institute
NIH, Bethesda
USA
Name/email consistency: high
- Antiretroviral activity of the aminothiol WR1065 against Human Immunodeficiency virus (HIV-1) in vitro and Simian Immunodeficiency virus (SIV) ex vivo. Poirier, M.C., Olivero, O.A., Hardy, A.W., Franchini, G., Borojerdi, J.P., Walker, V.E., Walker, D.M., Shearer, G.M. AIDS. Res. Ther (2009)
- Chemical-induced DNA damage and human cancer risk. Poirier, M.C. Nat. Rev. Cancer (2004)
- Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Poirier, M.C., Olivero, O.A., Walker, D.M., Walker, V.E. Toxicol. Appl. Pharmacol. (2004)
- Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. Poirier, M.C., Divi, R.L., Al-Harthi, L., Olivero, O.A., Nguyen, V., Walker, B., Landay, A.L., Walker, V.E., Charurat, M., Blattner, W.A. J. Acquir. Immune Defic. Syndr. (2003)
- The genotoxicity of tamoxifen: extent and consequences, Kona, Hawaii, January 23, 2003. Poirier, M.C., Schild, L.J. Mutagenesis (2003)
- Carcinogen macromolecular adducts and their measurement. Poirier, M.C., Santella, R.M., Weston, A. Carcinogenesis (2000)
- Incorporation of 3'-azido-3'-deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose. Poirier, M.C., Patterson, T.A., Slikker, W., Olivero, O.A. J. Acquir. Immune Defic. Syndr. (1999)









